Habiger David C 4

What Happened
David C. Habiger, a director of Boston Scientific Corp. (BSX), was granted 3,800 shares as an equity award on May 7, 2026. The award is restricted stock (transaction code A) with a reported aggregate value of $215,000; that implies an approximate per-share value of $56.58. This was an award/grant—not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-07; Form 4 filed: 2026-05-11 (filed within the required two business days).
• Transaction type/code: Award/Grant (A) — 3,800 restricted shares; total reported value $215,000.
• Vesting/conditions: Footnote indicates this is an annual equity award in restricted stock that vests in full upon the next annual meeting of stockholders. (Footnote F1)
• Shares owned after transaction: Not disclosed in the provided filing.
• No indication of a 10b5-1 plan, tax-withholding sale, or sale of underlying shares in this filing.

Context
Restricted stock awards to directors are common as part of annual compensation and do not represent an open-market buy or sell. Because the shares vest at the next annual meeting, they are subject to forfeiture until that time and should be viewed as routine director compensation rather than a direct signal of trading intent.